Botanical species · safety record

Euonymus atropurpureus

The EFSA Compendium of Botanicals holds 3 constituent measurements for Euonymus atropurpureus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Euonymus atropurpureus Jacq.

3Constituent measurements
0Safety records
2Cited sources
7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Euonymus atropurpureus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark
  • Bark of the branches and of the root
  • Root

What the records describe

Constituents measured

  • Alkaloids1
  • Cardenolides1
  • Digitoxigenin1

Plant parts

  • Leaves2
  • Unspecified1

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CardenolidesLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
DigitoxigeninUnspecifiedChromatographic testsNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. FUNG, SY. ALKALOIDS AND CARDENOLIDES IN 16 EUONYMUS TAXA. Biochemical systematics and ecology, 1986, vol. 14, no. 4, p. 371-373. DOI
  2. Bliss, C. A., Ramstad, Egil. Cardiac glycosides of Euonymus atropurpureus. II. A study of the structure of Euatroside and Euatromonoside. Journal of the american pharmaceutical association (1912-1977), 1957, vol. 46, p. 423-6.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue